TP53 and breast carcinoma: These results showed that breast cancer patients could be classified in more detail using TP53 signature in addition to intrinsic subtype classification, and suggested that the prognosis of patients with TP53 signature MT type is poor with or without molecular target oncodriver genes because of genomic instability.